Search

everythinglearnresearchcommunity

for

Search:↓

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Women with AGA have higher lipid levels, increasing heart disease risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Combining CO2 laser with platelet-rich plasma is more effective for treating acne scars than laser alone.

A 22-year-old homosexual man was diagnosed with secondary syphilis, genital warts, and HIV, highlighting the high STI risk in men who have sex with men.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.